Tokyo, Japan

Ryosuke Munakata

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 7.7

ph-index = 3

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 2010-2016

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Ryosuke Munakata: Innovator in Pharmaceutical Chemistry

Introduction

Ryosuke Munakata is a notable inventor based in Tokyo, Japan, recognized for his groundbreaking contributions to pharmaceutical chemistry. With a total of six patents to his name, he has made significant strides in addressing diseases related to amyloid protein accumulation, including Alzheimer's disease.

Latest Patents

One of Munakata's latest innovations involves chromane compounds, specifically a hydrate of N-[(4S)-2-amino-2',2′-dimethyldispiro[1,3-oxazole-4,4′-chromene-3′,3′′-oxetan]-6′-yl]-5-chloropyridine-2-carboxamide. This compound serves as a potential active ingredient in pharmaceutical compositions aimed at preventing or treating diseases associated with β-secretase activity, hydrolysis of β-secretase sites on β-amyloid precursor proteins, and accumulation of β-amyloid proteins. Notably, this includes its application in addressing Glaucoma, Mild Cognitive Impairment (MCI), and Alzheimer's disease.

Another significant patent of his involves similar chromane compounds that also function as active ingredients in pharmaceutical compositions targeting the same diseases. The consistency and relevance of his work highlight his commitment to advancing medical treatments for debilitating conditions.

Career Highlights

Ryosuke Munakata has had an impactful career, having collaborated with prestigious companies such as Astellas Pharma GmbH and Comentis, Inc. His work within these organizations has facilitated remarkable advancements in pharmaceutical developments, underlining his status as a key contributor in the field.

Collaborations

Throughout his career, Munakata has worked alongside talented individuals, including coworkers Kiyohiro Samizu and Noriyuki Kawano. These collaborations have further enriched his research and development efforts, fostering innovation through shared expertise and ideas.

Conclusion

Ryosuke Munakata's work epitomizes the intersection of innovation and medical science. With his valuable patents, he continues to pave the way for new therapeutic options that may eventually improve the lives of those affected by serious cognitive diseases. His contributions are a testament to the significant impact that dedicated inventors can have on society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…